Teladoc HealthTDOC
About: Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.
Employees: 5,600
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
100% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 2 (+1) [Q3]
26% more call options, than puts
Call options by funds: $60.8M | Put options by funds: $48.2M
9.84% less ownership
Funds ownership: 83.04% [Q2] → 73.2% (-9.84%) [Q3]
11% less funds holding
Funds holding: 398 [Q2] → 355 (-43) [Q3]
16% less capital invested
Capital invested by funds: $1.38B [Q2] → $1.15B (-$227M) [Q3]
35% less repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 126
42% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 102
Research analyst outlook
7 Wall Street Analysts provided 1 year price targets over the past 3 months
7 analyst ratings
Piper Sandler Jessica Tassan 32% 1-year accuracy 7 / 22 met price target | 38%upside $13 | Overweight Reiterated | 4 Dec 2024 |
Goldman Sachs David Roman 54% 1-year accuracy 7 / 13 met price target | 48%upside $14 | Buy Initiated | 15 Nov 2024 |
Deutsche Bank George Hill 50% 1-year accuracy 5 / 10 met price target | 27%upside $12 | Hold Maintained | 1 Nov 2024 |
Barclays Steve Valiquette 75% 1-year accuracy 9 / 12 met price target | 27%upside $12 | Overweight Maintained | 31 Oct 2024 |
TD Cowen Charles Rhyee 22% 1-year accuracy 2 / 9 met price target | 15%downside $8 | Hold Maintained | 31 Oct 2024 |
Financial journalist opinion
Based on 11 articles about TDOC published over the past 30 days
